Research Article

Comparative Pharmacokinetics of Seven Major Compounds in Normal and Atherosclerosis Mice after Oral Administration of Simiao Yong’an Decoction

Table 6

Main pharmacokinetic parameters of the seven compounds in mouse plasma after oral administration of SMYAD (mean ± SD, n = 5).

CompoundsGroupParameters
t1/2/htmax/hCmax/ng·mL−1AUC0–t/ng·mL−1·hAUC0–∞/ng·mL−1·hVz/F (L/mg)CLz/F (L/h/mg)

HarpagideNC8.40 ± 1.806.00 ± 2.19838.40 ± 126.546936.17 ± 533.237194.33 ± 588.3432.74 ± 7.644.90 ± 0.40
AS8.55 ± 3.974.00 ± 0.00939.74 ± 180.8311075.09 ± 2132.3816221.95 ± 5622.4224.34 ± 16.572.45 ± 0.87

Chlorogenic acidNC4.51 ± 1.101.13 ± 0.88266.84 ± 72.391109.84 ± 418.971257.70 ± 424.87247.01 ± 150.7130.37 ± 7.58
AS21.59 ± 9.160.25 ± 0.001128.91 ± 969.581560.11 ± 476.372637.51 ± 322.54302.49 ± 211.8913.49 ± 1.81

SwertiamarinNC4.43 ± 2.065.00 ± 4.971431.10 ± 636.235349.68 ± 1183.985401.77 ± 1243.8820.82 ± 11.265.82 ± 2.64
AS5.74 ± 1.900.90 ± 0.641335.08 ± 603.035542.40 ± 2011.027243.79 ± 3391.0055.16 ± 45.045.70 ± 1.93

SwerosideNC3.81 ± 0.560.40 ± 0.301793.48 ± 368.696983.11 ± 381.877083.75 ± 389.9916.99 ± 3.784.96 ± 0.28
AS6.56 ± 2.750.90 ± 0.641588.23 ± 496.617501.27 ± 1799.948926.84 ± 2117.6729.99 ± 14.264.29 ± 1.55

Angoroside CNC7.40 ± 4.760.85 ± 0.62288.62 ± 123.791732.42 ± 882.961865.70 ± 1053.21148.22 ± 76.2329.75 ± 24.10
AS7.33 ± 4.682.05 ± 1.19491.04 ± 238.941838.19 ± 298.231891.33 ± 226.37126.00 ± 102.7218.79 ± 2.39

LiquiritinNC16.98 ± 3.430.75 ± 0.63132.03 ± 57.09606.62 ± 229.46760.40 ± 333.88565.81 ± 116.6058.74 ± 30.94
AS13.54 ± 3.570.75 ± 0.6967.62 ± 33.62407.58 ± 115.29481.57 ± 137.03887.57 ± 397.8267.62 ± 33.62

IsoliquiritigeninNC6.65 ± 1.311.90 ± 2.13175.33 ± 49.021036.28 ± 144.061063.27 ± 144.39198.37 ± 58.5333.51 ± 4.41
AS6.01 ± 2.320.95 ± 0.60134.59 ± 101.80502.25 ± 165.65653.68 ± 251.34658.87 ± 555.5162.16 ± 23.35

Compared with the NC group, , .